Cargando…

Efficacy and safety of Telitacicept in patients with IgA nephropathy

Detalles Bibliográficos
Autores principales: Liang, Dongrui, Li, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626081/
https://www.ncbi.nlm.nih.gov/pubmed/37936774
http://dx.doi.org/10.12669/pjms.39.6.8393
_version_ 1785131268807065600
author Liang, Dongrui
Li, Xiaodong
author_facet Liang, Dongrui
Li, Xiaodong
author_sort Liang, Dongrui
collection PubMed
description
format Online
Article
Text
id pubmed-10626081
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Professional Medical Publications
record_format MEDLINE/PubMed
spelling pubmed-106260812023-11-07 Efficacy and safety of Telitacicept in patients with IgA nephropathy Liang, Dongrui Li, Xiaodong Pak J Med Sci Correspondence Professional Medical Publications 2023 /pmc/articles/PMC10626081/ /pubmed/37936774 http://dx.doi.org/10.12669/pjms.39.6.8393 Text en Copyright: © Pakistan Journal of Medical Sciences https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0 (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Liang, Dongrui
Li, Xiaodong
Efficacy and safety of Telitacicept in patients with IgA nephropathy
title Efficacy and safety of Telitacicept in patients with IgA nephropathy
title_full Efficacy and safety of Telitacicept in patients with IgA nephropathy
title_fullStr Efficacy and safety of Telitacicept in patients with IgA nephropathy
title_full_unstemmed Efficacy and safety of Telitacicept in patients with IgA nephropathy
title_short Efficacy and safety of Telitacicept in patients with IgA nephropathy
title_sort efficacy and safety of telitacicept in patients with iga nephropathy
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626081/
https://www.ncbi.nlm.nih.gov/pubmed/37936774
http://dx.doi.org/10.12669/pjms.39.6.8393
work_keys_str_mv AT liangdongrui efficacyandsafetyoftelitaciceptinpatientswithiganephropathy
AT lixiaodong efficacyandsafetyoftelitaciceptinpatientswithiganephropathy